Accendra Health
211 hedge funds and large institutions have $1.31B invested in Accendra Health in 2023 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 72 increasing their positions, 84 reducing their positions, and 39 closing their positions.
153% more call options, than puts
Call options by funds: $4.75M | Put options by funds: $1.88M
7.43% more ownership
Funds ownership: 98.83% → 106.26% (+7.4%)
8% less funds holding
Funds holding: 230 → 211 (-19)
8% less capital invested
Capital invested by funds: $1.44B → $1.31B (-$122M)
14% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 84
46% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 39
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$58.9M |
| 2 |
DM
Deerfield Management
New York
|
+$30M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$19.6M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$9.52M |
| 5 |
Two Sigma Investments
New York
|
+$5.34M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$6.13M |
| 2 |
EIP
Epoch Investment Partners
New York
|
-$5.07M |
| 3 |
BlackRock
New York
|
-$4.94M |
| 4 |
Morgan Stanley
New York
|
-$4.06M |
| 5 |
AG
Algert Global
San Francisco,
California
|
-$4.05M |
ACH Hedge Fund Activity: Q3 2023 in Review
211 of the 6,304 institutional investors tracked by Wall St. Rank reported a position in Accendra Health (ACH) for Q3 2023, worth a combined $1.31B — down 8.5% from $1.44B a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of ACH and 21 opened new positions — a net loss of 18 holders — while 84 trimmed existing stakes and 72 added.
The largest buyer was Pacer Advisors, opening a new position worth an estimated $58.9M. The largest seller was Wellington Management Group, cutting an estimated $6.13M.
- 211 institutional investors held Accendra Health (ACH) as of Q3 2023, down from 230 in Q2 2023.
- Funds reported $1.31B of Accendra Health stock for Q3 2023, down 8.5% quarter-over-quarter.
- 21 funds opened new Accendra Health positions in Q3 2023 and 39 closed out, a net change of -18 holders.
- The largest Accendra Health buyer in Q3 2023 was Pacer Advisors, an estimated $58.9M added.
- The largest Accendra Health seller in Q3 2023 was Wellington Management Group, an estimated $6.13M sold.
Based on aggregated 13F filings for Q3 2023.